Treatment-related adverse effects were reported in 97.2% of heavily pretreated patients with uterine serous carcinoma taking ...

Infusion bays designed with nurse input provide patients the choice between privacy and community while allowing support from loved ones.

Use of the 1.5T Elekta Unity MR-Linac was associated with reduced rates of erectile dysfunction at 6, 12, and 18 months in ...

The FDA has granted accelerated approval to avutometinib (VS-6766) plus defactinib (VS-6063) for the treatment of adult ...

The FDA approved the use of daratumumab and hyaluronidase-fihj (Darzalex Faspro) for patients who are newly diagnosed with ...

Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving communication.

Pediatric patients with high-risk neuroblastoma had significantly lower 5-year survival rates in induction and/or ...

Identity and Independence: Many AYAs are in a developmental stage where they are gaining autonomy. A cancer diagnosis can ...

Final data from the phase 3 ALCYONE trial support frontline use of daratumumab-based therapy for patients with ...

New data show strong overall survival rates, building on previously reported outcomes with efti plus pembrolizumab for head ...

The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...

Panelists discuss how medication adherence significantly impacts chronic myeloid leukemia (CML) treatment outcomes, with research showing even small differences between 90% and 95% adherence to ...